Semaglutide is a GLP-1 receptor agonist intended solely for research purposes. Clinical studies have demonstrated its considerable potential for appetite suppression, weight loss, and blood sugar management. Offered in dosages of 10mg, 20mg, and 30mg, this adaptable dosing makes it an outstanding choice for researchers investigating metabolic and weight loss therapies.
Key Benefits:
- Designed for research purposes only
- Proven effectiveness in appetite suppression and metabolic regulation
- Versatile dosing options (10mg, 20mg, 30mg)
- Cost-effective and accessible for scientific research
- Includes a complimentary injection pen
